And Li et al. found in their study that blocking IL-6 promoted the accumulation of CD8+ T cells and led to high expression of PD-L1 in colorectal cancer, enhancing the sensitivity of animals to PD-1 therapy (Li et al., 2022a). Here, IL6 is linked to colorectal cancer.